EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies

Venkata Sagi, Francis Murgatroyd iD, Lucas V A Boersma iD, Jaimie Manlucu, Bradley P Knight iD, Christophe Leclercq iD, Anish Amin, Ulrika Maria Birgersdotter-Green, Joseph Yat Sun Chan, Henri Roukoz, Mauro Biffi iD, Haris Haqqani iD und 6 weitere

Europace · 2024

DOI: 10.1093/europace/euae225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Venkata Sagi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Baptist Heart Specialists, 836 Prudential Drive, Suite 1700, Jacksonville, FL 32207 USA. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Device Removal. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The extravascular implantable cardioverter-defibrillator (EV ICD) has been shown to be safe and effective for patients at risk of sudden cardiac death, but little is known about EV ICD lead removal in humans. This analysis aimed to characterize the EV ICD lead removal experience thus far. Methods and results This was a retrospective analysis of lead removals from the EV ICD Pilot, Pivotal, and Continued Access Studies. Patients with a successful EV ICD implant who underwent lead removal were included. The main objective was lead removal success. Ancillary objectives included characterizing technique used, procedure complications, and reimplantation status. An EV ICD system was successfully implanted in 347 patients across the 3 studies (25.9% female; 53.4 ± 13.3 years; left ventricular ejection fraction: 39.7 ± 15.9). Of these patients, 29 (8.4%) underwent lead removal with a mean lead dwell time of 12.6 ± 14.3 months (0.2–58.4). The main reason for lead removal was lead dislodgement (n = 9, 31.0%). Lead removal was successful in 27/29 (93.1%) cases [100% (19/19) success rate <1 year and 80% (8/10) success rate >1 year post-implant]. Simple traction was used in 22/26 (84.6%) and extraction tools in 4/26 (15.4%) successful cases where technique was known. No complications were reported for any of the removal procedures. All 11 EV ICD reimplant attempts were successful.

Conclusion

Complete removal of the EV ICD lead was successful in 93.1% of cases, and simple traction was sufficient in most instances. Based on these results, lead removal from the substernal space was safe and achievable up to 3 years post-implant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableDevice RemovalHumansFemaleMiddle AgedMaleRetrospective StudiesAgedAdultTreatment OutcomeDeath, Sudden, CardiacPilot ProjectsTime FactorsElectric Countershock

Stichwörter der Autor:innen

ExplantExtractionExtravascular ICDLead removalSubsternal

Autor:innen und Institutionen

  • Baptist Heart Specialists, 836 Prudential Drive, Suite 1700, Jacksonville, FL 32207 USA.
  • King's College Hospital, London, UK.
  • Cardiology Department, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Cardiology Department, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Division of Cardiology, London Health Sciences Centre, London, ON, Canada.
  • Division of Cardiology, Northwestern University, Chicago, IL, USA.

ORCID-Profile: Francis Murgatroyd, Lucas V A Boersma, Bradley P Knight, Christophe Leclercq, Mauro Biffi, Haris Haqqani, Russell Denman, Paul Friedman, Ian Crozier

Förderung

  • Medtronic Inc

Zitieren

APA

Sagi, V., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., Knight, B. P., Leclercq, C., Amin, A., Birgersdotter-Green, U. M., Chan, J. Y. S., Roukoz, H., Biffi, M., Haqqani, H., Denman, R., Wiggenhorn, C., Holmes, T. R., Lulic, T., Friedman, P., & Crozier, I. (2024). Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies. Europace. https://doi.org/10.1093/europace/euae225

Vancouver

Sagi V, Murgatroyd F, Boersma LVA, Manlucu J, Knight BP, Leclercq C, et al. Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies. Europace. 2024. doi:10.1093/europace/euae225

BibTeX
@article{Sagi2024,
  author = {Sagi, Venkata and Murgatroyd, Francis and Boersma, Lucas V A and Manlucu, Jaimie and Knight, Bradley P and Leclercq, Christophe and Amin, Anish and Birgersdotter-Green, Ulrika Maria and Chan, Joseph Yat Sun and Roukoz, Henri and Biffi, Mauro and Haqqani, Haris and Denman, Russell and Wiggenhorn, Christopher and Holmes, Thomas R and Lulic, Thomas and Friedman, Paul and Crozier, Ian},
  title = {Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae225}
}
Kostenlos starten →